v3.26.1
Stockholders’ Deficit (Details Narrative) - USD ($)
3 Months Ended
Dec. 15, 2021
Mar. 31, 2026
Dec. 31, 2025
Jul. 12, 2024
Jan. 31, 2024
Jul. 31, 2023
Jun. 30, 2023
Class of Warrant or Right [Line Items]              
Ordinary stock, shares authorized   50,000,000 50,000,000        
Ordinary stock, par value   $ 0.001 $ 0.001        
Common stock, shares outstanding   3,205,000 3,205,000        
Ordinary stock, shares outstanding   3,205,000 3,205,000        
Temporary equity, shares authorized   21,962 22,664        
Sale of stock, price per share   $ 12.50          
Sale of stock, consideration received on transaction $ 115,000,000            
Share Price         $ 0.033 $ 0.033  
Shares price per share       $ 11.61     $ 0.033
Warrants exercisable to purchase of ordinary shares   1,690,000          
Public Warrants [Member]              
Class of Warrant or Right [Line Items]              
Sale of units in initial public offering 11,500,000            
Sale of stock, price per share $ 10.00            
Sale of stock, consideration received on transaction $ 115,000,000            
Share Price $ 11.50            
Warrants outstanding   11,500,000 11,500,000        
Warrants outstanding exercisable     5,750,000        
Class of warrants or rights redemption price per share 0.01            
Shares price per share $ 18.00            
Number of consecutive trading days for determining the volume weighted average price of share 20 days            
Class of warrants or rights period within the registration shall be effective from the consummation of business combination 60 days            
Volume weighted average price per share $ 9.20            
Percentage of funds raised to be used for consummating business combination 60.00%            
Class of warrants or rights exercise price percentage 115.00%            
Warrants exercise price market value 180.00%            
Private Warrants [Member]              
Class of Warrant or Right [Line Items]              
Warrants outstanding   330,000 330,000        
Warrants outstanding exercisable   165,000